Maternal plasma levels of complement Factor H in miscarriage and in normal pregnancy: A cohort study

•We examine if there is an association between CFH and miscarriage.•Median CFH levels were similar between first and second trimester up to 19.6 weeks.•CFH level were not correlated to gestational age.•CFH is not reduced in women with miscarriage, compared to normal pregnancy. The incidence of clini...

Full description

Saved in:
Bibliographic Details
Published inJournal of reproductive immunology Vol. 114; pp. 1 - 5
Main Authors Savaris, Ricardo Francalacci, Becker, Caroline, Guedes Neto, Ernesto de Paula
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.04.2016
Subjects
Online AccessGet full text
ISSN0165-0378
1872-7603
DOI10.1016/j.jri.2016.01.002

Cover

Abstract •We examine if there is an association between CFH and miscarriage.•Median CFH levels were similar between first and second trimester up to 19.6 weeks.•CFH level were not correlated to gestational age.•CFH is not reduced in women with miscarriage, compared to normal pregnancy. The incidence of clinically recognizable miscarriage in general population is up to 15%. It has been shown that complement Factor H (CFH) mRNA levels were increased in endometrium of women during early pregnancy, compared to non-pregnant women. We hypothesized that patients with miscarriage could have lower protein levels of CFH. The objectives of this prospective cohort is to measure plasma levels of Factor H in pregnancies up to 20 weeks, and to investigated whether there is an association between CFH and miscarriage. Plasma levels of CFH were measured in a cohort of pregnant women, ranging from 3 to 19.6 weeks who attended a gynecologic emergency unit in Brazil. Subjects had a blood sample obtained at the first consultation and were followed up to 24 weeks. After reaching outcome, subjects were divided into 4 groups: (1) miscarriage at entry the study, (2) normal pregnancy, (3) those that evolved to miscarriage, and (4) a control group of 6 non-pregnant, fertile proven women. Kruskal–Wallis test was used for statistical analysis. From 193 eligible women, 4 were excluded due technical problems and 33 were lost to follow-up. Median levels (range) of CFH were 989.2μg/mL (372–1644) n=64; 1042μg/mL (600.7–1915) n=74; 1089μg/mL (813.7–1250) n=12; 1004μg/mL (901.7–1335) n=6 in groups 1–3 and control, respectively; p=0.46—Kruskal–Wallis; post-hoc power (1-β)=31.6%. Therefore, median plasma levels of CFH are not different between women with miscarriage or normal pregnancy up to 19.6 weeks.
AbstractList The incidence of clinically recognizable miscarriage in general population is up to 15%. It has been shown that complement Factor H (CFH) mRNA levels were increased in endometrium of women during early pregnancy, compared to non-pregnant women. We hypothesized that patients with miscarriage could have lower protein levels of CFH. The objectives of this prospective cohort is to measure plasma levels of Factor H in pregnancies up to 20 weeks, and to investigated whether there is an association between CFH and miscarriage. Plasma levels of CFH were measured in a cohort of pregnant women, ranging from 3 to 19.6 weeks who attended a gynecologic emergency unit in Brazil. Subjects had a blood sample obtained at the first consultation and were followed up to 24 weeks. After reaching outcome, subjects were divided into 4 groups: (1) miscarriage at entry the study, (2) normal pregnancy, (3) those that evolved to miscarriage, and (4) a control group of 6 non-pregnant, fertile proven women. Kruskal-Wallis test was used for statistical analysis. From 193 eligible women, 4 were excluded due technical problems and 33 were lost to follow-up. Median levels (range) of CFH were 989.2 μg/mL (372-1644) n=64; 1042 μg/mL (600.7-1915) n=74; 1089 μg/mL (813.7-1250) n=12; 1004 μg/mL (901.7-1335) n=6 in groups 1-3 and control, respectively; p=0.46-Kruskal-Wallis; post-hoc power (1-β)=31.6%. Therefore, median plasma levels of CFH are not different between women with miscarriage or normal pregnancy up to 19.6 weeks.
The incidence of clinically recognizable miscarriage in general population is up to 15%. It has been shown that complement Factor H (CFH) mRNA levels were increased in endometrium of women during early pregnancy, compared to non-pregnant women. We hypothesized that patients with miscarriage could have lower protein levels of CFH. The objectives of this prospective cohort is to measure plasma levels of Factor H in pregnancies up to 20 weeks, and to investigated whether there is an association between CFH and miscarriage. Plasma levels of CFH were measured in a cohort of pregnant women, ranging from 3 to 19.6 weeks who attended a gynecologic emergency unit in Brazil. Subjects had a blood sample obtained at the first consultation and were followed up to 24 weeks. After reaching outcome, subjects were divided into 4 groups: (1) miscarriage at entry the study, (2) normal pregnancy, (3) those that evolved to miscarriage, and (4) a control group of 6 non-pregnant, fertile proven women. Kruskal-Wallis test was used for statistical analysis. From 193 eligible women, 4 were excluded due technical problems and 33 were lost to follow-up. Median levels (range) of CFH were 989.2 mu g/mL (372-1644) n =64; 1042 mu g/mL (600.7-1915) n =74; 1089 mu g/mL (813.7-1250) n =12; 1004 mu g/mL (901.7-1335) n =6 in groups 1-3 and control, respectively; p =0.46-Kruskal-Wallis; post-hoc power (1- beta )=31.6%. Therefore, median plasma levels of CFH are not different between women with miscarriage or normal pregnancy up to 19.6 weeks.
•We examine if there is an association between CFH and miscarriage.•Median CFH levels were similar between first and second trimester up to 19.6 weeks.•CFH level were not correlated to gestational age.•CFH is not reduced in women with miscarriage, compared to normal pregnancy. The incidence of clinically recognizable miscarriage in general population is up to 15%. It has been shown that complement Factor H (CFH) mRNA levels were increased in endometrium of women during early pregnancy, compared to non-pregnant women. We hypothesized that patients with miscarriage could have lower protein levels of CFH. The objectives of this prospective cohort is to measure plasma levels of Factor H in pregnancies up to 20 weeks, and to investigated whether there is an association between CFH and miscarriage. Plasma levels of CFH were measured in a cohort of pregnant women, ranging from 3 to 19.6 weeks who attended a gynecologic emergency unit in Brazil. Subjects had a blood sample obtained at the first consultation and were followed up to 24 weeks. After reaching outcome, subjects were divided into 4 groups: (1) miscarriage at entry the study, (2) normal pregnancy, (3) those that evolved to miscarriage, and (4) a control group of 6 non-pregnant, fertile proven women. Kruskal–Wallis test was used for statistical analysis. From 193 eligible women, 4 were excluded due technical problems and 33 were lost to follow-up. Median levels (range) of CFH were 989.2μg/mL (372–1644) n=64; 1042μg/mL (600.7–1915) n=74; 1089μg/mL (813.7–1250) n=12; 1004μg/mL (901.7–1335) n=6 in groups 1–3 and control, respectively; p=0.46—Kruskal–Wallis; post-hoc power (1-β)=31.6%. Therefore, median plasma levels of CFH are not different between women with miscarriage or normal pregnancy up to 19.6 weeks.
Highlights • We examine if there is an association between CFH and miscarriage. • Median CFH levels were similar between first and second trimester up to 19.6 weeks. • CFH level were not correlated to gestational age. • CFH is not reduced in women with miscarriage, compared to normal pregnancy.
Author Savaris, Ricardo Francalacci
Becker, Caroline
Guedes Neto, Ernesto de Paula
Author_xml – sequence: 1
  givenname: Ricardo Francalacci
  orcidid: 0000-0002-2779-5443
  surname: Savaris
  fullname: Savaris, Ricardo Francalacci
  email: rsavaris@hcpa.edu.br
– sequence: 2
  givenname: Caroline
  surname: Becker
  fullname: Becker, Caroline
– sequence: 3
  givenname: Ernesto de Paula
  surname: Guedes Neto
  fullname: Guedes Neto, Ernesto de Paula
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26828816$$D View this record in MEDLINE/PubMed
BookMark eNqNUk1vEzEUtFAR_YAfwAX5yCXhPW92vQEJqaooRSriAJytF-9LcfDawXYq5d_jJe2lEoWTLXtm_Dwzp-IoxMBCvESYI2D3ZjPfJDdXdTsHnAOoJ-IEe61muoPmSJzUi3YGje6PxWnOGwDUsMRn4lh1vep77E7E8JkKp0Bebj3lkaTnW_ZZxrW0cdx6HjkUeUm2xCSvpAtydNlSSo5uWFIYpqMQ0zgpJL4JFOz-rTyv7B8xFZnLbtg_F0_X5DO_uFvPxPfLD98urmbXXz5-uji_ntnFEsvMWqVasosBlV7phWVsGmoVgdLY2Y64p5WloddIeo2tUhpwScBW9926AdWcidcH3W2Kv3aci5mGZe8pcNxlg7pvVVtt6P8DqrtOLat3FfrqDrpbjTyYbXIjpb25N7EC9AFgU8w58dpYV6i4GEoi5w2CmeIyG1PjMlNcBtDAn4HxAfNe_DHOuwOnxsS3jpPJ1nGwPLjEtpghukfZ7x-wrXfBWfI_ec95E3dTGer_TVYGzNepQlODsG0AFoBVYPl3gX88_huNgdPl
CitedBy_id crossref_primary_10_3389_fimmu_2024_1351898
crossref_primary_10_3390_ijms251910549
crossref_primary_10_1182_blood_2016_07_728253
Cites_doi 10.1177/1933719108317585
10.1084/jem.20061022
10.1016/j.molimm.2015.02.030
10.1002/sim.1783
10.1053/beog.2000.0123
10.1002/uog.10109
10.1038/nri3761
10.1016/j.placenta.2010.03.010
10.1111/cei.12371
10.1016/j.molimm.2010.01.021
10.1157/13106775
10.1111/j.1471-0528.1988.tb06870.x
10.1056/NEJMcp1005330
10.1016/j.biocel.2007.06.012
ContentType Journal Article
Copyright 2016 Elsevier Ireland Ltd
Elsevier Ireland Ltd
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Copyright_xml – notice: 2016 Elsevier Ireland Ltd
– notice: Elsevier Ireland Ltd
– notice: Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
DOI 10.1016/j.jri.2016.01.002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1872-7603
EndPage 5
ExternalDocumentID 26828816
10_1016_j_jri_2016_01_002
S0165037815300401
1_s2_0_S0165037815300401
Genre Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AAAJQ
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CJTIS
CNWQP
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMG
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LUGTX
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OQ.
OZT
P-8
P-9
P2P
PC.
PH~
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SEL
SES
SEW
SIN
SPCBC
SSH
SSI
SSZ
T5K
UHS
WUQ
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
ID FETCH-LOGICAL-c491t-cc225ac4d127b74ce133a52a02716c6ae8abcad871a7f15227019a0ec786f3023
IEDL.DBID AIKHN
ISSN 0165-0378
IngestDate Thu Sep 04 21:22:52 EDT 2025
Fri Sep 05 11:16:21 EDT 2025
Wed Feb 19 01:58:19 EST 2025
Tue Jul 01 01:26:23 EDT 2025
Thu Apr 24 22:53:46 EDT 2025
Fri Feb 23 02:16:50 EST 2024
Tue Feb 25 20:02:27 EST 2025
Tue Aug 26 16:31:54 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Complement Factor H
Miscarriage
Early pregnancy
Language English
License Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c491t-cc225ac4d127b74ce133a52a02716c6ae8abcad871a7f15227019a0ec786f3023
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ORCID 0000-0002-2779-5443
PMID 26828816
PQID 1776629378
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1785250018
proquest_miscellaneous_1776629378
pubmed_primary_26828816
crossref_citationtrail_10_1016_j_jri_2016_01_002
crossref_primary_10_1016_j_jri_2016_01_002
elsevier_sciencedirect_doi_10_1016_j_jri_2016_01_002
elsevier_clinicalkeyesjournals_1_s2_0_S0165037815300401
elsevier_clinicalkey_doi_10_1016_j_jri_2016_01_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-04-01
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: 2016-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Journal of reproductive immunology
PublicationTitleAlternate J Reprod Immunol
PublicationYear 2016
Publisher Elsevier Ireland Ltd
Publisher_xml – name: Elsevier Ireland Ltd
References Stabile, Nicolaides, Bach, Teisner, Rodeck, Westergaard, Grudzinskas (bib0085) 1988; 95
Abdallah, Daemen, Kirk, Pexsters, Naji, Stalder, Gould, Ahmed, Guha, Syed, Bottomley, Timmerman, Bourne (bib0005) 2011; 38
Savaris, Hamilton, Lessey, Giudice (bib0080) 2008; 15
Johnson, Gustavii (bib0035) 1987; 95
NICE (bib0065) 2012; 154
Banadakoppa, Chauhan, Havemann, Balakrishnan, Dominic, Yallampalli (bib0010) 2014; 177
Julious (bib0040) 2004; 23
Lee, Oh, Choi, Park, Han, Kim do, Choi, Kim, Cho (bib0050) 2007; 39
Regan, Rai (bib0075) 2000; 14
Derzsy, Prohaszka, Rigo, Fust, Molvarec (bib0020) 2010; 47
Janeway, Travers, Walport, Shlomchik (bib0030) 2001
Branch, Gibson, Silver (bib0015) 2010; 363
Girardi, Yarilin, Thurman, Holers, Salmon (bib0025) 2006; 203
Lynch, Salmon (bib0055) 2010; 31
Micheloud, Sarmiento, Teijeiro, Jensen, Rodriguez Molina, Fernandez-Cruz, Carbone (bib0060) 2007; 35
Kolev, Le Friec, Kemper (bib0045) 2014; 14
Regal, Gilbert, Burwick (bib0070) 2015; 67
Regal (10.1016/j.jri.2016.01.002_bib0070) 2015; 67
Julious (10.1016/j.jri.2016.01.002_bib0040) 2004; 23
NICE (10.1016/j.jri.2016.01.002_bib0065) 2012; 154
Stabile (10.1016/j.jri.2016.01.002_bib0085) 1988; 95
Johnson (10.1016/j.jri.2016.01.002_bib0035) 1987; 95
Regan (10.1016/j.jri.2016.01.002_bib0075) 2000; 14
Lynch (10.1016/j.jri.2016.01.002_bib0055) 2010; 31
Branch (10.1016/j.jri.2016.01.002_bib0015) 2010; 363
Derzsy (10.1016/j.jri.2016.01.002_bib0020) 2010; 47
Janeway (10.1016/j.jri.2016.01.002_bib0030) 2001
Banadakoppa (10.1016/j.jri.2016.01.002_bib0010) 2014; 177
Kolev (10.1016/j.jri.2016.01.002_bib0045) 2014; 14
Savaris (10.1016/j.jri.2016.01.002_bib0080) 2008; 15
Lee (10.1016/j.jri.2016.01.002_bib0050) 2007; 39
Micheloud (10.1016/j.jri.2016.01.002_bib0060) 2007; 35
Abdallah (10.1016/j.jri.2016.01.002_bib0005) 2011; 38
Girardi (10.1016/j.jri.2016.01.002_bib0025) 2006; 203
References_xml – volume: 23
  start-page: 1921
  year: 2004
  end-page: 1986
  ident: bib0040
  article-title: Sample sizes for clinical trials with normal data
  publication-title: Stat. Med.
– volume: 14
  start-page: 839
  year: 2000
  end-page: 854
  ident: bib0075
  article-title: Epidemiology and the medical causes of miscarriage
  publication-title: Baillieres Best Pract. Res. Clin. Obstet. Gynaecol.
– volume: 95
  start-page: 97
  year: 1987
  end-page: 99
  ident: bib0035
  article-title: Complement components in normal pregnancy
  publication-title: Acta Pathol. Microbiol. Immunol. Scand. C
– volume: 14
  start-page: 811
  year: 2014
  end-page: 820
  ident: bib0045
  article-title: Complement—tapping into new sites and effector systems
  publication-title: Nat. Rev. Immunol.
– volume: 363
  start-page: 1740
  year: 2010
  end-page: 1747
  ident: bib0015
  article-title: Clinical practice. Recurrent miscarriage
  publication-title: N. Engl. J. Med.
– volume: 154
  start-page: 1
  year: 2012
  end-page: 39
  ident: bib0065
  publication-title: Ectopic Pregnancy and Miscarriage—Diagnosis and Initial Management in Early Pregnancy of Ectopic Pregnancy and Miscarriage
– volume: 177
  start-page: 743
  year: 2014
  end-page: 749
  ident: bib0010
  article-title: Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta
  publication-title: Clin. Exp. Immunol.
– volume: 39
  start-page: 2265
  year: 2007
  end-page: 2277
  ident: bib0050
  article-title: Differentially expressed genes implicated in unexplained recurrent spontaneous abortion
  publication-title: Int. J. Biochem. Cell Biol.
– volume: 35
  start-page: 90
  year: 2007
  end-page: 94
  ident: bib0060
  article-title: Hypocomplementemia in the absence of autoantibodies in women with recurrent pregnancy loss
  publication-title: Allergol. Immunopathol. (Madr.)
– year: 2001
  ident: bib0030
  article-title: The complement system and innate immunity
  publication-title: Immunobiology: the Immune System in Health and Disease
– volume: 47
  start-page: 1500
  year: 2010
  end-page: 1506
  ident: bib0020
  article-title: Activation of the complement system in normal pregnancy and preeclampsia
  publication-title: Mol. Immunol.
– volume: 203
  start-page: 2165
  year: 2006
  end-page: 2175
  ident: bib0025
  article-title: Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
  publication-title: J. Exp. Med.
– volume: 31
  start-page: 561
  year: 2010
  end-page: 567
  ident: bib0055
  article-title: Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications
  publication-title: Placenta
– volume: 38
  start-page: 497
  year: 2011
  end-page: 502
  ident: bib0005
  article-title: Limitations of current definitions of miscarriage using mean gestational sac diameter and crown-rump length measurements: a multicenter observational study
  publication-title: Ultrasound Obstet. Gynecol.
– volume: 67
  start-page: 56
  year: 2015
  end-page: 70
  ident: bib0070
  article-title: The complement system and adverse pregnancy outcomes
  publication-title: Mol. Immunol.
– volume: 15
  start-page: 797
  year: 2008
  end-page: 816
  ident: bib0080
  article-title: Endometrial gene expression in early pregnancy: lessons from human ectopic pregnancy
  publication-title: Reprod. Sci.
– volume: 95
  start-page: 281
  year: 1988
  end-page: 285
  ident: bib0085
  article-title: Complement factors in fetal and maternal blood and amniotic fluid during the second trimester of normal pregnancy
  publication-title: Br. J. Obstet. Gynaecol.
– volume: 154
  start-page: 1
  year: 2012
  ident: 10.1016/j.jri.2016.01.002_bib0065
– volume: 15
  start-page: 797
  year: 2008
  ident: 10.1016/j.jri.2016.01.002_bib0080
  article-title: Endometrial gene expression in early pregnancy: lessons from human ectopic pregnancy
  publication-title: Reprod. Sci.
  doi: 10.1177/1933719108317585
– volume: 203
  start-page: 2165
  year: 2006
  ident: 10.1016/j.jri.2016.01.002_bib0025
  article-title: Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20061022
– volume: 67
  start-page: 56
  year: 2015
  ident: 10.1016/j.jri.2016.01.002_bib0070
  article-title: The complement system and adverse pregnancy outcomes
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2015.02.030
– volume: 23
  start-page: 1921
  year: 2004
  ident: 10.1016/j.jri.2016.01.002_bib0040
  article-title: Sample sizes for clinical trials with normal data
  publication-title: Stat. Med.
  doi: 10.1002/sim.1783
– volume: 14
  start-page: 839
  year: 2000
  ident: 10.1016/j.jri.2016.01.002_bib0075
  article-title: Epidemiology and the medical causes of miscarriage
  publication-title: Baillieres Best Pract. Res. Clin. Obstet. Gynaecol.
  doi: 10.1053/beog.2000.0123
– volume: 38
  start-page: 497
  year: 2011
  ident: 10.1016/j.jri.2016.01.002_bib0005
  article-title: Limitations of current definitions of miscarriage using mean gestational sac diameter and crown-rump length measurements: a multicenter observational study
  publication-title: Ultrasound Obstet. Gynecol.
  doi: 10.1002/uog.10109
– volume: 14
  start-page: 811
  year: 2014
  ident: 10.1016/j.jri.2016.01.002_bib0045
  article-title: Complement—tapping into new sites and effector systems
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3761
– volume: 31
  start-page: 561
  year: 2010
  ident: 10.1016/j.jri.2016.01.002_bib0055
  article-title: Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications
  publication-title: Placenta
  doi: 10.1016/j.placenta.2010.03.010
– volume: 177
  start-page: 743
  year: 2014
  ident: 10.1016/j.jri.2016.01.002_bib0010
  article-title: Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta
  publication-title: Clin. Exp. Immunol.
  doi: 10.1111/cei.12371
– volume: 47
  start-page: 1500
  year: 2010
  ident: 10.1016/j.jri.2016.01.002_bib0020
  article-title: Activation of the complement system in normal pregnancy and preeclampsia
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2010.01.021
– year: 2001
  ident: 10.1016/j.jri.2016.01.002_bib0030
  article-title: The complement system and innate immunity
– volume: 35
  start-page: 90
  year: 2007
  ident: 10.1016/j.jri.2016.01.002_bib0060
  article-title: Hypocomplementemia in the absence of autoantibodies in women with recurrent pregnancy loss
  publication-title: Allergol. Immunopathol. (Madr.)
  doi: 10.1157/13106775
– volume: 95
  start-page: 281
  year: 1988
  ident: 10.1016/j.jri.2016.01.002_bib0085
  article-title: Complement factors in fetal and maternal blood and amniotic fluid during the second trimester of normal pregnancy
  publication-title: Br. J. Obstet. Gynaecol.
  doi: 10.1111/j.1471-0528.1988.tb06870.x
– volume: 363
  start-page: 1740
  year: 2010
  ident: 10.1016/j.jri.2016.01.002_bib0015
  article-title: Clinical practice. Recurrent miscarriage
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMcp1005330
– volume: 95
  start-page: 97
  year: 1987
  ident: 10.1016/j.jri.2016.01.002_bib0035
  article-title: Complement components in normal pregnancy
  publication-title: Acta Pathol. Microbiol. Immunol. Scand. C
– volume: 39
  start-page: 2265
  year: 2007
  ident: 10.1016/j.jri.2016.01.002_bib0050
  article-title: Differentially expressed genes implicated in unexplained recurrent spontaneous abortion
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2007.06.012
SSID ssj0017091
Score 2.1249897
Snippet •We examine if there is an association between CFH and miscarriage.•Median CFH levels were similar between first and second trimester up to 19.6 weeks.•CFH...
Highlights • We examine if there is an association between CFH and miscarriage. • Median CFH levels were similar between first and second trimester up to 19.6...
The incidence of clinically recognizable miscarriage in general population is up to 15%. It has been shown that complement Factor H (CFH) mRNA levels were...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Abortion, Spontaneous - blood
Adult
Complement Factor H
Complement Factor H - metabolism
Early pregnancy
Female
Humans
Miscarriage
Obstetrics and Gynecology
Pregnancy
Pregnancy Trimester, First - blood
Pregnancy Trimester, Second - blood
Prospective Studies
Title Maternal plasma levels of complement Factor H in miscarriage and in normal pregnancy: A cohort study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0165037815300401
https://www.clinicalkey.es/playcontent/1-s2.0-S0165037815300401
https://dx.doi.org/10.1016/j.jri.2016.01.002
https://www.ncbi.nlm.nih.gov/pubmed/26828816
https://www.proquest.com/docview/1776629378
https://www.proquest.com/docview/1785250018
Volume 114
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbp5tJL6bvbNEGFkkOJu9bb7m0JXbYtCYEmkJuQZTlsSLyLvTnsJb-9M35sCE020KONxhKaGc2MNfMNIV-CE7nKJY98ErJI8iIFlcpE5FghlRPKcIXVyEfHenomf52r8y1y2NfCYFpld_a3Z3pzWndvRt1ujhaz2egPFuLEwiSgsyiKEAJtc5FqNSDb45-_p8frywQTt43zYHyEBP3lZpPmdVnNMMFLN-Cd3c-VB8zTY-5nY4YmL8mLzn-k43aJr8hWKF-T_ZMWgHp1QE_v6qnqA7pPT-6gqVdvSH7kWtBnugCv-drRK8wZqum8oE1uefOvkE6aHjx0SmclBTHwrgIpvQjUlTm-KtHNhS9U4QLROlbf6Zhin91qSRuw2rfkbPLj9HAadX0WIi9Ttoy8B6V2XuaMm8xIHyBudYo7iFiZ9tqFxGXe5RBaOVOAvecI4e7i4E2iC2w69I4MynkZPhAaiyCUzwuZIvKgSBOeZ0pILXIPtlKqIYn77bW-AyHHXhhXts82u7TAEYscsTGzwJEh-bomWbQIHJsG855nti8thcPQgn3YRGQeIgp1p861ZbbmNrb_iNyQyDXlPal9asLPvThZZCPmuZVhfgMTGaM1eGAm2TQmwbvomMGY960srjeGa4igE6Y__t_CdshzfGozkz6RwbK6CbvgdC2zPfLs2y3b61TrLyfpKRE
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5V5QAXxJtAgUVCPaCa2Pt0uFUVUYCmqkQq9bZa766rVMWJ7PSQS387M2s7FaIEiaszG1s7Mzsz9jffEPIhWO6lFyxxeSgSwcoRuFTBE5uVQlouNZPYjTw9UZMz8e1cnu-Qo74XBmGV3dnfnunxtO6uDLvdHC7n8-EPbMRJuc7BZ9EUoQS6JyTXiOv7dLPBeWQ6bcfmgXSC4v2nzQjyuqznCO9Skbqze7VyR3D6W_IZg9D4EXnYZY_0sH3Ax2QnVE_I_mlLP70-oLPbbqrmgO7T01ti6vVT4qe2pXymS8iZf1p6hYihhi5KGpHl8U0hHccJPHRC5xUFI3C2Bhu9CNRWHi9VmOTCP9ThArk61p_pIcUpu_WKRqraZ-Rs_GV2NEm6KQuJE6NslTgHLm2d8BnThRYuQNVqJbNQr2bKKRtyWzjrobCyuoRoz5DA3abB6VyVOHLoOdmtFlV4SWjKA5fOl2KEvIN8lDNfSC4U9w4ipZADkvbba1xHQY6TMK5MjzW7NKARgxoxaWZAIwPycbNk2fJvbBNmvc5M31gKR6GB6LBtkb5rUWg6Z25MZhpmUvOHwQ2I2Kz8zWb_dcP3vTkZVCOi3KqwuIYbaa0U5F863yaT45foNAOZF60tbjaGKaif80y9-r8He0fuT2bTY3P89eT7a_IAf2kxSntkd1VfhzeQfq2Kt9G9fgGtfSnc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Maternal+plasma+levels+of+complement+Factor+H+in+miscarriage+and+in+normal+pregnancy%3A+A+cohort+study&rft.jtitle=Journal+of+reproductive+immunology&rft.au=Savaris%2C+Ricardo+Francalacci&rft.au=Becker%2C+Caroline&rft.au=Guedes+Neto%2C+Ernesto+de+Paula&rft.date=2016-04-01&rft.issn=0165-0378&rft.volume=114&rft.spage=1&rft.epage=5&rft_id=info:doi/10.1016%2Fj.jri.2016.01.002&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0165-0378&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0165-0378&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0165-0378&client=summon